Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING

Descrizione del progetto

Un agente economico per la guarigione delle ferite

Le ferite complesse, come le ulcere diabetiche o venose, o le ferite croniche da ustioni, sono difficili da trattare e guariscono lentamente, aumentando il rischio di infezioni. In questi casi si fa ampio utilizzo dell’argento come agente antimicrobico, ma la sua produzione è costosa e poco sicura dal punto di vista ambientale. Per affrontare questa sfida medica, il progetto NABIHEAL, finanziato dall’UE, mira a sviluppare materiali multifunzionali basati sulle nanotecnologie come alternativa economica all’argento per la guarigione delle ferite. I biomateriali proposti consentiranno anche il rilascio controllato di molecole terapeutiche nelle medicazioni delle ferite, prevenendo la formazione di biofilm e agevolando la guarigione.

Obiettivo

Complex wounds are a global health problem with significant impact on the health care economy. In developed countries alone, they impact the quality of life of more than 2% of total population. Complex wounds, including chronic wounds or major burns, are highly susceptible to microbial infection and biofilm formation, and difficult to treat. Moreover, silver is a widely used metal in antimicrobial products to treat wound infections. However, silver-based products are expensive, and show several drawbacks due to costs, as well as environmental and safety concerns.
The NABIHEAL project will develop multifunctional biomaterials, from proof-of-concept (TRL 3) to the preclinical regulatory stage (TRL 5), to improve wound management. The resulting biomaterials will enable affordable treatment of wound infections or prevention of complications during all phases of the wound healing process.
In the short and medium term, NABIHEAL will develop at least two innovative multifunctional wound-healing biomaterials, using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a game-changing alternative to silver in wound-healing dressings.
A consortium comprising 5 SMEs and 9 academic institutions, with expertise in wound healing product development, evaluation and commercialization, nanotechnology, safety, and regulatory affairs, will join forces to address these ambitious objectives.

Campo scientifico

CORDIS classifica i progetti con EuroSciVoc, una tassonomia multilingue dei campi scientifici, attraverso un processo semi-automatico basato su tecniche NLP.

Coordinatore

CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED M.P.
Contribution nette de l'UE
€ 981 420,11
Indirizzo
CALLE MONFORTE DE LEMOS 5
28029 Madrid
Spagna

Mostra sulla mappa

Regione
Comunidad de Madrid Comunidad de Madrid Madrid
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 1 258 740,90

Partecipanti (14)